KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Shares Outstanding (2016 - 2025)

Idexx Laboratories has reported Shares Outstanding over the past 17 years, most recently at $79.7 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $79.7 million for Q4 2025, down 26.08% from a year ago — trailing twelve months through Dec 2025 was $79.7 million (down 26.08% YoY), and the annual figure for FY2025 was $79.7 million, down 26.08%.
  • Shares Outstanding for Q4 2025 was $79.7 million at Idexx Laboratories, down from $108.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding for IDXX hit a ceiling of $108.3 million in Q3 2025 and a floor of $79.7 million in Q4 2025.
  • Median Shares Outstanding over the past 5 years was $107.3 million (2023), compared with a mean of $106.0 million.
  • Biggest five-year swings in Shares Outstanding: grew 0.72% in 2021 and later fell 26.08% in 2025.
  • Idexx Laboratories' Shares Outstanding stood at $106.9 million in 2021, then grew by 0.29% to $107.2 million in 2022, then grew by 0.29% to $107.5 million in 2023, then increased by 0.31% to $107.8 million in 2024, then fell by 26.08% to $79.7 million in 2025.
  • The last three reported values for Shares Outstanding were $79.7 million (Q4 2025), $108.3 million (Q3 2025), and $108.0 million (Q2 2025) per Business Quant data.